# Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus

> **NCT02201199** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 36 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** insulin glargine U200 HOE901
- **DRUG:** insulin glargine U500 HOE901
- **DRUG:** insulin glargine U100 HOE901

## Key facts

- **NCT ID:** NCT02201199
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02201199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02201199, "Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With Lantus". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02201199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*